|
Patheon makes the production path for pharmaceutical firms a little easier to tread. With about a dozen facilities in Canada, Europe, and the US, the company provides contract manufacturing services to pharmaceutical and biotech companies worldwide. Focusing primarily on prescription drugs, it makes products in conventional solid, semi-solid, and liquid dosages. It also makes controlled-release, lyophilized (freeze-dried), sterilized, and antibiotic formulations. Through its Pharmaceutical Development Services (PDS) unit, the company helps clients develop dosage formulations for clinical trials and provides packaging and labeling services. Private equity firm JLL Partners owns a controlling stake in Patheon.
|
| | | Contact Information | |
Address: |
2100 Syntex Crt.
Mississauga, Ontario L5N 7K9, Canada
| | Phone: | 905-821-4001 | | Fax: | 905-812-2121 |
|
| Financial
Highlights | | Fiscal Year End: | October | | Revenue (2008): | 717.30 M | | Revenue Growth (1 yr): | 5.90% | | Employees (2008): | 4,500 | | Employee Growth (1 yr): | (-3.20%) |
|
|
Key People
| | • |
Chairman:
Peter A. W. Green
| | • |
CEO and Director:
Wesley P. (Wes) Wheeler
| | • |
President, Patheon Europe:
Aldo Braca
|
|
|
